The 19 references in paper S. Serebrova Yu., A. Prokofiev B., M. Zhuravleva V., N. Eremenko N., С. Сереброва Ю., А. Прокофьев Б., М. Журавлева В., Н. Еременко Н. (2018) “Римские критерии IV функциональных заболеваний желудочно-кишечного тракта в оценке взаимозаменяемости лекарственных препаратов: взгляд врача - клинического фармаколога // Rome IV criteria of functional gastrointestinal diseases in evaluation of drugs interchangeability: through the eyes of a clinical pharmacologist” / spz:neicon:vedomostincesmp:y:2017:i:4:p:221-227

1
Federal Law of the Russian Federation of 12.04.2010, No. 61-FZ «On Circulation of Medicines». Available from: http://www.consultant.ru/document/cons_doc_LAW_99350 (in Russian).
(check this in PDF content)
2
Bukatina TM, Pasternak EYu, Romanov BK, Alyautdin RN, Lepakhin VK, Kazakov AS, et al. Information on the decisions of foreign regulatory authorities. Safety and Risk of Pharmacotherapy 2017; 5(1): 39–43 (in Russian).
(check this in PDF content)
3
Scientific substantiation, development and improvement of methodology for assessment of medicinal products interchangeability. Research report (intermediate). FSBI «SCEEMP» of the Ministry of Health of Russia; advisors: Romanov BK, Prokofiev AB, Yagudina RI; prepared by: Alyautdin RN, Zhuravleva MV. Moscow; 2015. 274 p. No. SR 115111740009. Deposited in CITIS on 16.02.2016, No. IKRBS 216021650027 (in Russian).
(check this in PDF content)
4
Moiseev SV. Cordarone or amiodarone in the treatment and prevention of arrhythmias? Clinical Pharmacology and Therapy 2010; 19(3): 18–22 (in Russian).
(check this in PDF content)
5
Nardi R, Masina M, Cioni G, Leandri P, Zucceri P. Generic — equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 2. Misconceptions, doubts and critical aspects when using generic drugs in the real world. Italian Journal of Medicine 2014; 8(2): 88–98.
(check this in PDF content)
6
Reshetko OV, Lutsevich KA. Individual bioequivalence: concept, research and variability (a review). Pharmaceutical Chemistry Journal 2009; 43(8): 3–8 (in Russian).
(check this in PDF content)
7
Lewek P. Generic drugs: The benefits and risks of making the switch. J Fam Pract 2010; 59(11): 634–40.
(check this in PDF content)
8
EUDRAGIT®. Acrylic polymers for solid oral dosage forms. Available from: http:// www.rofarma.com/allegati/97.pdf.
(check this in PDF content)
9
Sun H, Liu D, Li Y, Tang X, Cong Y. Preparation andin vitro/in vivo characterization of enteric-coated nanoparticles loaded with the antihypertensive peptide VLPVPR. Int J Nanomedicine 2014; 9(1): 1709–16.
(check this in PDF content)
10
Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci. 2003; 6(1): 33–66.
(check this in PDF content)
11
Drossman AD. Rome IV — Functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016; 150(6): 1257–61.
(check this in PDF content)
12
Oudenhove L, Levy RL, Crowell MD, Drossman DA, Halpert AD, Keefer L, et al. Biopsychosocial aspects of functional gastrointestinal disorders: how central and environmental processes contribute to the development and expression of functional gastrointestinal disorders. Gastroenterology 2016; 150(6): 1355–67.
(check this in PDF content)
13
Camilleri M, Bueno L, Andresen V, De Ponti F, Choi MG, Lembo A. Pharmacologic, pharmacokinetic, and pharmacogenomic aspects of functional gastrointestinal disorders. Gastroenterology 2016; 150(6): 1319–31.
(check this in PDF content)
14
Itopride. Registration certificate. Available from: https://goo.gl/ QviFuK.
(check this in PDF content)
15
Chuchalin AG, Hohlov AL, eds. Federal guidance on the use of drugs (formulary system). Issue XVIII. Moscow: Vidoks; 2017 (in Russian).
(check this in PDF content)
16
Poynard T, Regimbeau C, Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2001; 15(3): 355–61.
(check this in PDF content)
17
Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2011 Aug 10; (8): CD003460.
(check this in PDF content)
18
Serebrova SYu. Comparative clinical pharmacology of modern proton pump inhibitors. Dr. Med. Sci [dissertation]. Moscow; 2009 (in Russian).
(check this in PDF content)
19
Scientific substantiation, development and improvement of methodology for assessment of medicinal products interchangeability. Research report (intermediate). FSBI «SCEEMP» of the Ministry of Health of Russia; advisors: Romanov BK, Prokofiev AB, Yagudina RI; prepared by: Alyautdin RN, Zhuravleva MV. Moscow; 2016.
(check this in PDF content)